Surmodics to Webcast First Quarter 2017 Earnings Conference Call on February 2
January 24 2017 - 8:05AM
Business Wire
Webcast is Live at 7:30 a.m. (CT)
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical
device and in vitro diagnostic technologies to the healthcare
industry, today announced that it will host a live webcast of its
first quarter fiscal 2017 conference call on Thursday, February 2,
at 7:30 a.m. CT (8:30 a.m. ET). The Company will issue an
earnings news release earlier that morning.
Gary Maharaj, president and chief executive officer, and Andy
LaFrence, vice president of finance and information systems and
chief financial officer, will recap the first quarter 2017
financial results and accomplishments. To access the webcast, go to
the investor relations portion of the Company’s website at
www.surmodics.com the day of the conference call and click on the
webcast icon.
An audio replay will be available beginning at 10:30 a.m. CT on
Thursday, February 2, until 10:30 a.m. CT on Thursday,
February 9, and can be accessed by dialing 888-203-1112 and
entering conference call ID passcode 8582113. In addition, the
conference call audio and transcript will be archived on the
Company’s website following the call.
About Surmodics, Inc.
Surmodics is the global leader in surface modification
technologies for intravascular medical devices and a leading
provider of chemical components for in vitro diagnostic (IVD) tests
and microarrays. Following two recent acquisitions of Creagh
Medical and NorMedix, the Company is executing a key growth
strategy for its medical device business by expanding to offer
total intravascular product solutions to its medical device
customers. The combination of proprietary surface technologies,
along with enhanced device design, development and manufacturing
capabilities, enables Surmodics to significantly increase the value
it offers with highly differentiated intravascular solutions
designed and engineered to meet the most demanding requirements.
With this focus on offering total product solutions, Surmodics’
mission remains to improve the detection and treatment of disease
by using its technology to provide solutions to difficult medical
device and diagnostic challenges. Surmodics is headquartered in
Eden Prairie, Minnesota. For more information about the company,
visit www.surmodics.com. The content of Surmodics’ website is not
part of this press release or part of any filings that the company
makes with the SEC.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170124005344/en/
Surmodics, Inc.Andy LaFrence,
952-500-7000ir@surmodics.com
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Aug 2024 to Sep 2024
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Sep 2023 to Sep 2024